Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Zyneyro ApS
APS
Active
Advertising protection
CVR 42057428
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2021 · 5 years old
10 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Zyneyro ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SS
Steen Søren Klysner
Management
Management
2024
Former (1)
PH
Peter Horn Møller
Management
Management
2021 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
UG
Ulrik Gether
Board of Directors
Board of Directors
2021
JØ
Jacob Ørndrup
Chairman
Chairman
2021
KL
Kenneth Lindegaard Madsen
Board of Directors
Board of Directors
2021
AT
Andreas Toft Sørensen
Board of Directors
Board of Directors
2021
EV
Erik Vinther
Board of Directors
Board of Directors
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Marigold Maturation Fund K/S
Company
20–24.99%
20–24.99%
2026
UGether ApS
Company
15–19.99%
15–19.99%
2026
KLMBio ApS
Company
15–19.99%
15–19.99%
2026
IFO ApS
Company
15–19.99%
15–19.99%
2026
Marigold Innovation ApS
Company
15–19.99%
15–19.99%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Zyneyro ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network